Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
24.52
0.00 (0.00%)
Sep 15, 2026, 7:38 AM EDT - Market open
Attovia Therapeutics Revenue
Attovia Therapeutics had revenue of $450.00K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $1.80M. In the year 2025, Attovia Therapeutics had annual revenue of $1.35M.
Revenue (ttm)
$1.80M
Revenue Growth
n/a
P/S Ratio
621.87
Revenue / Employee
$40,909
Employees
44
Market Cap
1.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.35M | - | - |
| Dec 31, 2024 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ATTO News
- 11 days ago - Attovia Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 12 days ago - Attovia reports Q2 EPS ($4.88), consensus ($4.61) - TheFly
- 12 days ago - Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 13 days ago - Attovia Therapeutics Quarterly report: Q2 2026 - Filings
- 13 days ago - Attovia Therapeutics Earnings release: Q2 2026 - Filings
- 15 days ago - Attovia initiated with an Outperform at LifeSci Capital - TheFly
- 15 days ago - Attovia initiated with an Outperform at Leerink - TheFly
- 15 days ago - Attovia initiated with a Buy at Citi - TheFly